Skip to main content
Top

Cardiovascular Diabetology

Issue 1/2005

Content (18 Articles)

Open Access Review

Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice

Jeanette Schultz Johansen, Alex K Harris, David J Rychly, Adviye Ergul

Open Access Original investigation

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

Cristiana Vitale, Giuseppe Mercuro, Carlotta Castiglioni, Alessandra Cornoldi, Arianna Tulli, Massimo Fini, Maurizio Volterrani, Giuseppe MC Rosano

Open Access Editorial

Statins research unfinished saga: desirability versus feasibility

Enrique Z Fisman, Yehuda Adler, Alexander Tenenbaum

Open Access Original investigation

Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population

N Al-Daghri, R Chetty, PG McTernan, K Al-Rubean, O Al-Attas, AF Jones, S Kumar

Open Access Methodology

Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines

Cory Russell, Peggy Dunbar, Sonia Salisbury, Ingrid Sketris, George Kephart

Open Access Review

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons

Alexander Tenenbaum, Michael Motro, Enrique Z Fisman

Open Access Original investigation

Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients

A Fiorentini, A Perciaccante, A Paris, P Serra, L Tubani

Open Access Original investigation

Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes

Rebecca L Pollex, Mary Mamakeesick, Bernard Zinman, Stewart B Harris, Anthony JG Hanley, Robert A Hegele

Open Access Original investigation

Prevalence of antiplatelet therapy in patients with diabetes

Shaun R Miller, Benjamin Littenberg, Charles D MacLean

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.